HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric K Rowinsky Selected Research

Epidermal Growth Factor (EGF)

8/2004Safety, pharmacokinetics, and activity of ABX-EGF, a fully human anti-epidermal growth factor receptor monoclonal antibody in patients with metastatic renal cell cancer.
3/2004Preclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric K Rowinsky Research Topics

Disease

85Neoplasms (Cancer)
02/2015 - 01/2002
16Neutropenia
10/2011 - 05/2002
12Colorectal Neoplasms (Colorectal Cancer)
02/2011 - 01/2002
7Adenocarcinoma
04/2024 - 01/2003
7Fatigue
04/2024 - 07/2002
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012 - 05/2002
7Disease Progression
10/2011 - 05/2003
7Breast Neoplasms (Breast Cancer)
06/2010 - 01/2003
7Exanthema (Rash)
06/2010 - 08/2004
6Thrombocytopenia (Thrombopenia)
01/2011 - 07/2003
5Fever (Fevers)
04/2024 - 07/2002
4Pancreatic Neoplasms (Pancreatic Cancer)
04/2024 - 07/2007
4Neoplasm Metastasis (Metastasis)
04/2024 - 01/2004
4Diarrhea
12/2006 - 07/2002
3Sarcoma (Soft Tissue Sarcoma)
06/2011 - 08/2007
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2010 - 02/2006
3Squamous Cell Carcinoma of Head and Neck
01/2010 - 02/2006
3Nausea
06/2009 - 07/2002
3Vomiting
10/2006 - 07/2002
2Asthenia
06/2010 - 10/2006
2Mucositis
06/2010 - 04/2003
2Hematologic Neoplasms (Hematological Malignancy)
02/2010 - 09/2007
2Anorexia
06/2009 - 07/2002
2Hyperbilirubinemia
10/2008 - 07/2003
2Renal Cell Carcinoma (Grawitz Tumor)
09/2007 - 08/2004
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
09/2007 - 12/2004
2Melanoma (Melanoma, Malignant)
02/2007 - 07/2002
2Febrile Neutropenia
02/2006 - 01/2006
2Lung Neoplasms (Lung Cancer)
12/2004 - 02/2003
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2003 - 01/2002
1Chills
04/2024

Drug/Important Bio-Agent (IBA)

14ErbB Receptors (EGF Receptor)IBA
02/2011 - 01/2002
10Monoclonal AntibodiesIBA
03/2010 - 01/2003
8Cetuximab (Erbitux)FDA Link
08/2012 - 03/2005
6Transaminases (Aminotransferases)IBA
04/2024 - 07/2002
6Proteins (Proteins, Gene)FDA Link
10/2020 - 01/2002
5Paclitaxel (Taxol)FDA LinkGeneric
03/2012 - 02/2003
5Cisplatin (Platino)FDA LinkGeneric
02/2012 - 02/2003
5DNA (Deoxyribonucleic Acid)IBA
11/2010 - 01/2003
5Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2010 - 07/2003
4GemcitabineFDA Link
04/2024 - 10/2003
4Tyrosine Kinase InhibitorsIBA
07/2010 - 05/2002
4TOR Serine-Threonine KinasesIBA
06/2010 - 06/2003
4Irinotecan (Camptosar)FDA LinkGeneric
12/2008 - 08/2004
4Sirolimus (Rapamycin)FDA Link
01/2008 - 06/2003
4Pemetrexed (MTA)FDA Link
05/2007 - 01/2006
3EnzymesIBA
04/2024 - 07/2002
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 02/2007
3Carboplatin (JM8)FDA LinkGeneric
03/2012 - 12/2006
3TrabectedinIBA
05/2010 - 01/2002
3troxacitabineIBA
12/2009 - 01/2002
3LigandsIBA
12/2005 - 01/2004
3Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2005 - 02/2003
3CamptothecinIBA
11/2005 - 01/2003
3exatecan (DX 8951f)IBA
08/2005 - 07/2003
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2004 - 01/2003
3PlatinumIBA
08/2004 - 05/2002
2Bexarotene (LGD1069)FDA Link
03/2012 - 02/2012
2NucleosidesIBA
02/2012 - 01/2002
2Hormones (Hormone)IBA
12/2011 - 08/2004
2cixutumumabIBA
12/2011 - 09/2007
2Insulin-Like PeptidesIBA
12/2011 - 11/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
10/2011 - 02/2003
2Sorafenib (BAY 43-9006)FDA Link
06/2011 - 09/2005
2temsirolimusFDA Link
06/2010 - 10/2006
2Immunoglobulin G (IgG)IBA
03/2010 - 02/2010
2Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
02/2010 - 02/2010
2Cytotoxins (Cytolysins)IBA
02/2010 - 05/2003
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2010 - 01/2002
2Phosphotransferases (Kinase)IBA
02/2010 - 07/2003
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2010 - 09/2007
2taxaneIBA
01/2009 - 10/2003
2Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2008 - 10/2006
2Thymidylate SynthaseIBA
12/2008 - 11/2004
2CreatinineIBA
10/2008 - 01/2006
2Lapatinib (GW572016)FDA Link
07/2008 - 08/2007
2AntibodiesIBA
09/2007 - 07/2004
2tetracycline CMT-3IBA
08/2007 - 10/2004
2VitaminsIBA
01/2007 - 02/2006
2Growth Factor ReceptorsIBA
09/2005 - 06/2003
2Docetaxel (Taxotere)FDA Link
11/2004 - 08/2004
2Biomarkers (Surrogate Marker)IBA
08/2004 - 08/2004
2Epidermal Growth Factor (EGF)IBA
08/2004 - 03/2004
2Fluorouracil (Carac)FDA LinkGeneric
01/2004 - 04/2003
2Farnesyltranstransferase (Farnesyltransferase)IBA
10/2003 - 10/2003
2Trastuzumab (Herceptin)FDA Link
10/2003 - 01/2003
2Gefitinib (Iressa)FDA Link
01/2003 - 05/2002
2Topotecan (Hycamtin)FDA LinkGeneric
05/2002 - 01/2002
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2024
1Alkaline PhosphataseIBA
04/2024
1130-nm albumin-bound paclitaxelIBA
04/2024
1Alanine Transaminase (SGPT)IBA
04/2024
1Deubiquitinating EnzymesIBA
10/2020
1Bortezomib (Velcade)FDA Link
10/2020

Therapy/Procedure

22Therapeutics
08/2012 - 01/2002
10Drug Therapy (Chemotherapy)
04/2024 - 01/2003
4Radiotherapy
01/2010 - 03/2004
2Drug Tapering
06/2010 - 10/2006
2Aftercare (After-Treatment)
06/2007 - 07/2003
1Injections
04/2024